Controlling Amyloid β-Peptide Fibril Formation with Protease-stable Ligands
Lars O. Tjernberg(Karolinska University Hospital), Christer Nordstedt(Eli Lilly (United States))
Cited by 229
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation
|Journal of Biological Chemistry|1999|358